Paper3815420
Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide.
Berry J and 2 others. Cancer Immunol Immunother, 1987. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide. Papers, record 3815420. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3815420
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Modulation of natural killer cell activity in stage I postmenopausal breast cancer patients on low-dose aminoglutethimide.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoglutethimide | Major topic |
| Breast Neoplasms | Major topic |
| Killer Cells, Natural | Major topic |
| Aged | |
| Cell Line | |
| Cytotoxicity, Immunologic | |
| Estradiol | |
| Female | |
| Humans | |
| Menopause | |
| Middle Aged |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6221746 | Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6221746 | PubMed |
| 2 | 3919830 | Variation in natural killer activity in peripheral blood during the menstrual cycle. | Br Med J (Clin Res Ed) | 1985 | https://conductscience.org/library/papers/3919830 | PubMed |
| 3 | 7334070 | Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity. | J Clin Immunol | 1981 | https://conductscience.org/library/papers/7334070 | PubMed |
| 4 | 6682769 | Aminoglutethimide for the treatment of advanced postmenopausal breast cancer. | Eur J Cancer Clin Oncol | 1983 | https://conductscience.org/library/papers/6682769 | PubMed |
| 5 | 7138766 | Natural killer (NK) activity in peripheral blood lymphocytes of patients with benign and malignant breast disease. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7138766 | PubMed |
| 6 | 4688315 | Source of estrogen production in postmenopausal women. | J Clin Endocrinol Metab | 1973 | https://conductscience.org/library/papers/4688315 | PubMed |
| 7 | 6420047 | Effect on natural killer and antibody-dependent cellular cytotoxicity of adjuvant cytotoxic chemotherapy including melphalan in breast cancer. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6420047 | PubMed |
| 8 | 6684948 | Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6684948 | PubMed |
| 9 | 6249490 | The use of aminoglutethimide in the treatment of patients with metastatic carcinoma of the breast. | Cancer | 1980 | https://conductscience.org/library/papers/6249490 | PubMed |
| 10 | 722074 | beta-Estradiol reduces natural killer cells in mice. | J Immunol | 1978 | https://conductscience.org/library/papers/722074 | PubMed |
| 11 | 194681 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. | Cancer | 1977 | https://conductscience.org/library/papers/194681 | PubMed |
| 12 | 263348 | Aminoglutethimide inhibits extraglandular estrogen production in postmenopausal women with breast carcinoma. | J Clin Endocrinol Metab | 1978 | https://conductscience.org/library/papers/263348 | PubMed |
| 13 | 4015950 | Effective inhibition by low dose aminoglutethimide of peripheral aromatization in postmenopausal breast cancer patients. | Br J Cancer | 1985 | https://conductscience.org/library/papers/4015950 | PubMed |
| 14 | 6944530 | Natural cytotoxicity of peripheral blood lymphocytes and regional lymph node cells in breast cancer in women. | J Natl Cancer Inst | 1981 | https://conductscience.org/library/papers/6944530 | PubMed |
| 15 | 6977516 | Trimethoprim-induced augmentation of human natural killer activity in vitro. | Immunopharmacology | 1982 | https://conductscience.org/library/papers/6977516 | PubMed |
| 16 | 7085128 | Studies of human natural killer cells. I. In vivo parameters affecting normal cytotoxic function. | Int J Cancer | 1982 | https://conductscience.org/library/papers/7085128 | PubMed |
| 17 | 3981483 | Hormonal modulation of human natural killer cell activity in vitro. | J Reprod Immunol | 1985 | https://conductscience.org/library/papers/3981483 | PubMed |
| 18 | 163658 | Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. | Blood | 1975 | https://conductscience.org/library/papers/163658 | PubMed |
| 19 | 25290166 | Do NK cells play a role in anti-tumor surveillance? | Immunol Today | 1980 | https://conductscience.org/library/papers/25290166 | PubMed |
| 20 | 4054302 | Oestrogen as an inhibitor of human NK cell cytolysis. | FEBS Lett | 1985 | https://conductscience.org/library/papers/4054302 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38590244 | Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patients With Early Breast Cancer Receiving Adjuvant Endocrine Therapy. | Integr Cancer Ther | 2024 | https://conductscience.org/library/papers/38590244 | PubMed |
| 26455641 | Endocrine resistance in breast cancer--An overview and update. | Mol Cell Endocrinol | 2015 | https://conductscience.org/library/papers/26455641 | PubMed |
| 8738607 | Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8738607 | PubMed |
| 8738601 | Animal models of breast cancer: their diversity and role in biomedical research. | Breast Cancer Res Treat | 1996 | https://conductscience.org/library/papers/8738601 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3815420
GET https://conductscience.org/api/papers/v1/3815420/references?page=2